ALERS — Eurobio Scientific SA Share News
0.000.00%
- €253.72m
- €241.20m
- €168.60m
French and Benelux stocks-Factors to watch
Brief: Eurobio Scientific Acquires Biomedical Diagnostics NV
Brief: Eurobio Scientific Closes Partnership With Nextstage AM
Brief: Eurobio Scientific Announces CE Mark For New Proprietary COVID-19 Test
Brief: Eurobio Scientific FY Net Result Down At EUR 60.5 Mln
Brief: Eurobio Scientific Launches New Test For Detection Of Omicron BA.x, BA.2, Delta Variants
Eurobio Scientific rises on strategic partnership with NextStage AM
Brief: Eurobio Scientific Signs Partnership With Nextstage AM
Brief: Eurobio Scientific FY Revenue At 184.1 Million Euros
Brief: Eurobio Scientific Enters Distribution Contract For First HIV Saliva Self-Test In France
Brief: Eurobio Scientific Obtains CE Marking For COVID-19 Test, Detection Of Omicron, Delta Variants
Brief: Eurobio Scientific Launches PCR Test For Covid-19 Diagnostic
Brief: Eurobio Scientific Invests In Usense
Brief: Eurobio Scientific H1 Net Profit Up At 33.1 Million Euros
Brief: Eurobio Scientific Receives USD 430,000 Milestone Payment From Allergan
Brief: Eurobio Scientific H1 Revenue At EUR 95.7 Million, Up 54% Y/y
Brief: Eurobio Scientific FY Net Profit Up At EUR 73.5 Mln
Brief: Eurobio Scientific FY Revenue Up 220% At 189 Million Euros
Brief: Eurobio Scientific Expands Range Of Covid-19 Tests With Antigenic Rapid Test